Larvol Delta - Formycon-and-Bioeq-announce-submission-of-the-marketing-authorization-application-for-FYB201-a-biosimilar-candidate-to-Lucentis-ranibizumab-to-the-European-Medicines-Agency-EMA

FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus, Teva

https://pipelinereview.com/index.php/2021063078585/Antibodies/Formycon-and-Bioeq-announce-submission-of-the-marketing-authorization-application-for-FYB201-a-biosimilar-candidate-to-Lucentis-ranibizumab-to-the-European-Medicines-Agency-EM.html

Jun 30, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next